{"id":"intravenous-tenecteplase","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Bleeding (major and minor)"},{"rate":"0.5-1","effect":"Intracranial hemorrhage"},{"rate":"5-10","effect":"Hypotension"},{"rate":null,"effect":"Reperfusion arrhythmias"},{"rate":"<1","effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tenecteplase is a genetically engineered variant of natural tissue plasminogen activator (tPA) with enhanced fibrin specificity and longer half-life. It binds to fibrin in thrombi and catalyzes the conversion of plasminogen to plasmin, which degrades the fibrin matrix of blood clots. This fibrinolytic action rapidly restores blood flow in occluded vessels, making it effective for acute thrombotic events.","oneSentence":"Tenecteplase is a tissue plasminogen activator (tPA) that converts plasminogen to plasmin, which breaks down fibrin clots to restore blood flow.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:16:53.157Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute myocardial infarction (ST-elevation MI)"},{"name":"Acute ischemic stroke"}]},"trialDetails":[{"nctId":"NCT07294209","phase":"PHASE4","title":"Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients","status":"RECRUITING","sponsor":"Southwest Hospital, China","startDate":"2025-12-19","conditions":"Acute Ischemic Stroke Patients","enrollment":798},{"nctId":"NCT07203625","phase":"PHASE4","title":"Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-20","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion","enrollment":316},{"nctId":"NCT07253181","phase":"PHASE3","title":"Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-06","conditions":"Acute Ischemic Stroke, Large Vessel Occlusion, Transportation of Patients","enrollment":572},{"nctId":"NCT07476898","phase":"PHASE3","title":"Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window","status":"NOT_YET_RECRUITING","sponsor":"First Hospital of China Medical University","startDate":"2026-03-01","conditions":"Stroke","enrollment":864},{"nctId":"NCT07475949","phase":"PHASE3","title":"Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":352},{"nctId":"NCT07475936","phase":"","title":"Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":392},{"nctId":"NCT07460713","phase":"NA","title":"Advancing Reperfusion Therapy for Ischemic Stroke: Direct Transfer to Angiography Suite for Patients With Suspected Large Vessel Occlusion","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-31","conditions":"Ischemic Stroke, Large Vessel Occlusion","enrollment":568},{"nctId":"NCT06018181","phase":"","title":"Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice","status":"COMPLETED","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2023-09-28","conditions":"Ischemic Stroke, Acute","enrollment":2408},{"nctId":"NCT06241677","phase":"NA","title":"Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-04-15","conditions":"CVA (Cerebrovascular Accident)","enrollment":260},{"nctId":"NCT07375953","phase":"PHASE2","title":"Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK)","status":"NOT_YET_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-03-01","conditions":"Ischemic Stroke","enrollment":120},{"nctId":"NCT07375966","phase":"PHASE2","title":"Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)","status":"NOT_YET_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-03-01","conditions":"Ischemic Stroke","enrollment":198},{"nctId":"NCT07419997","phase":"","title":"A Multicenter, Retrospective, Observational Cohort Study on Intravenous Thrombolysis Beyond the Time Window for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-29","conditions":"Stroke","enrollment":2600},{"nctId":"NCT05701956","phase":"PHASE3","title":"Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion","status":"COMPLETED","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2023-03-16","conditions":"Basilar Artery Occlusion, Acute Cerebrovascular Accident, Stroke Due to Basilar Artery Occlusion","enrollment":330},{"nctId":"NCT07369999","phase":"PHASE3","title":"Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Xiangya Hospital of Central South University","startDate":"2026-02-01","conditions":"Mild Disabling Acute Ischemic Stroke","enrollment":1062},{"nctId":"NCT06658197","phase":"PHASE3","title":"Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-25","conditions":"Stroke, Ischemic, Stroke, Acute, Thrombosis, Brain","enrollment":850},{"nctId":"NCT07283159","phase":"PHASE2","title":"Tenecteplase Plus Urinary Kallidinogenase for Acute Ischemic Stroke (TUKIS)","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-01-20","conditions":"Ischemic Stroke","enrollment":200},{"nctId":"NCT07347626","phase":"PHASE3","title":"Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis","status":"NOT_YET_RECRUITING","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2026-03-01","conditions":"Acute Ischemic Stroke","enrollment":786},{"nctId":"NCT07271342","phase":"","title":"Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-11-30","conditions":"Stroke","enrollment":10000},{"nctId":"NCT07318948","phase":"NA","title":"BALANCE Trial Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632","status":"NOT_YET_RECRUITING","sponsor":"Bo Wu","startDate":"2026-01-01","conditions":"Acute Ischemic Stroke","enrollment":1600},{"nctId":"NCT06987305","phase":"PHASE3","title":"Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window","status":"RECRUITING","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2025-10-21","conditions":"Stroke, Acute Ischemic","enrollment":820},{"nctId":"NCT06210633","phase":"","title":"Prospective Registry of Endovascular Thrombectomy for eXtra-Large Ischemic Stroke","status":"RECRUITING","sponsor":"Zhongming Qiu","startDate":"2024-01-20","conditions":"Acute Ischemic Stroke (AIS), Acute Ischemic Stroke From Large Vessel Occlusion","enrollment":1000},{"nctId":"NCT05604638","phase":"PHASE3","title":"Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Guangxi Medical University","startDate":"2024-04-24","conditions":"Acute Ischemic Stroke","enrollment":348},{"nctId":"NCT07092709","phase":"PHASE3","title":"Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-08-14","conditions":"Acute Ischemic Stroke","enrollment":912},{"nctId":"NCT05363397","phase":"PHASE2","title":"Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke","status":"RECRUITING","sponsor":"The Florey Institute of Neuroscience and Mental Health","startDate":"2023-09-27","conditions":"Acute Ischemic Stroke","enrollment":80},{"nctId":"NCT06221371","phase":"PHASE3","title":"Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-01-25","conditions":"Ischemic Stroke, Acute, Thrombolysis, Endovascular Treatment","enrollment":391},{"nctId":"NCT06196320","phase":"PHASE3","title":"Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-01-24","conditions":"Ischemic Stroke, Acute","enrollment":452},{"nctId":"NCT07047014","phase":"PHASE3","title":"Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-07-30","conditions":"Stroke, Ischemic, Medium Vessel Occlusions","enrollment":596},{"nctId":"NCT06954155","phase":"PHASE3","title":"Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-05-30","conditions":"Stroke","enrollment":330},{"nctId":"NCT04526951","phase":"PHASE3","title":"TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2020-10-30","conditions":"Central Retinal Artery Occlusion","enrollment":81},{"nctId":"NCT06320431","phase":"PHASE3","title":"ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632","status":"RECRUITING","sponsor":"University of Calgary","startDate":"2024-09-26","conditions":"Acute Ischemic Stroke AIS, Stroke Acute, Stroke, Acute, Stroke Ischemic","enrollment":4000},{"nctId":"NCT07168278","phase":"PHASE3","title":"Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2025-11-01","conditions":"Acute Ischemic Stroke, Large Vessel Occlusion, Tenecteplase","enrollment":794},{"nctId":"NCT06878066","phase":"PHASE3","title":"Thrombolysis in Factor Xa-inhibitors Trial","status":"RECRUITING","sponsor":"Guri Hagberg","startDate":"2025-03-14","conditions":"Stroke, Stroke (in Patients With Atrial Fibrillation), Ischemic Stroke","enrollment":300},{"nctId":"NCT06010628","phase":"PHASE4","title":"Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2024-02-01","conditions":"Stroke, Ischemic","enrollment":1440},{"nctId":"NCT07073469","phase":"PHASE3","title":"Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Stroke Ischemic","enrollment":330},{"nctId":"NCT07094763","phase":"NA","title":"Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2025-08-05","conditions":"Acute Ischemic Stroke","enrollment":406},{"nctId":"NCT06414499","phase":"PHASE3","title":"Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-07-09","conditions":"Minor Ischemic Stroke","enrollment":1386},{"nctId":"NCT04965038","phase":"PHASE3","title":"Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion","status":"RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2022-10-10","conditions":"Central Retinal Artery Occlusion","enrollment":422},{"nctId":"NCT05199194","phase":"PHASE3","title":"Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke","status":"RECRUITING","sponsor":"Hospital Moinhos de Vento","startDate":"2022-05-27","conditions":"Stroke, Ischemic, Stroke, Acute","enrollment":398},{"nctId":"NCT05199662","phase":"PHASE3","title":"Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT","status":"RECRUITING","sponsor":"Hospital Moinhos de Vento","startDate":"2022-01-20","conditions":"Ischemic Stroke, Acute","enrollment":466},{"nctId":"NCT04733742","phase":"PHASE2, PHASE3","title":"Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke","status":"COMPLETED","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2022-05-09","conditions":"Stroke, Acute, Stroke, Ischemic","enrollment":550},{"nctId":"NCT06571149","phase":"PHASE4","title":"Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2025-03-14","conditions":"Ischemic Stroke","enrollment":906},{"nctId":"NCT02301910","phase":"PHASE3","title":"Single Bolus Recombinant Nonimmunogenic Staphylokinase Versus Single Bolus Tenecteplase (Metalyse) in STEMI","status":"COMPLETED","sponsor":"Supergene, LLC","startDate":"2014-05-16","conditions":"Myocardial Infarction","enrollment":382},{"nctId":"NCT05635786","phase":"","title":"Early Recanalization After Intravenous Thrombolysis With Tenecteplase Versus Alteplase in Distal Vessel Occlusion Strokes","status":"COMPLETED","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2023-01-02","conditions":"Acute Distal Vessel Occlusion Stroke","enrollment":319},{"nctId":"NCT06115070","phase":"PHASE4","title":"Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Thrombosis, Acute Ischemic Stroke (AIS)","enrollment":390},{"nctId":"NCT06841965","phase":"PHASE3","title":"Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Stroke, Acute Ischemic Stroke","enrollment":280},{"nctId":"NCT06749834","phase":"PHASE3","title":"Intravenous Thrombolysis and NOAC","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-01-27","conditions":"Acute Ischemic Stroke","enrollment":280},{"nctId":"NCT06841978","phase":"PHASE3","title":"Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Stroke, Acute Ischemic Stroke","enrollment":306},{"nctId":"NCT02398656","phase":"PHASE3","title":"A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2015-04-01","conditions":"Stroke, Acute","enrollment":1274},{"nctId":"NCT04454788","phase":"PHASE3","title":"Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel Occlusion","status":"TERMINATED","sponsor":"University of Melbourne","startDate":"2020-08-01","conditions":"Ischemic Stroke","enrollment":242},{"nctId":"NCT04915729","phase":"PHASE3","title":"A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2021-06-22","conditions":"Stroke","enrollment":1489},{"nctId":"NCT06352632","phase":"PHASE3","title":"ACT-GLOBAL Adaptive Platform Trial for Stroke","status":"RECRUITING","sponsor":"The George Institute","startDate":"2024-09-26","conditions":"Stroke","enrollment":20000},{"nctId":"NCT06559436","phase":"NA","title":"Extending the Time Window for Intravenous Tenecteplase in Patients With Distal Medium Vessel Occlusions Stroke","status":"RECRUITING","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2024-10-02","conditions":"Acute Ischemic Stroke","enrollment":560},{"nctId":"NCT05827042","phase":"PHASE3","title":"Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion","status":"RECRUITING","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2023-05-09","conditions":"Basilar Artery Occlusion, Acute Cerebrovascular Accident, Stroke Due to Basilar Artery Occlusion","enrollment":338},{"nctId":"NCT06556446","phase":"","title":"Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2024-01-01","conditions":"Ischemic Stroke","enrollment":2800},{"nctId":"NCT06498323","phase":"PHASE4","title":"Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT","status":"RECRUITING","sponsor":"Mahidol University","startDate":"2022-08-03","conditions":"Intravenous, Thrombosis, Acute Ischemic Stroke","enrollment":160},{"nctId":"NCT05203224","phase":"PHASE2","title":"Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2022-02-18","conditions":"Ischemic Stroke","enrollment":300},{"nctId":"NCT02814409","phase":"PHASE3","title":"Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis","status":"COMPLETED","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2016-12-15","conditions":"Ischemic Stroke","enrollment":1858},{"nctId":"NCT05141305","phase":"PHASE3","title":"Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2022-01-19","conditions":"Ischemic Stroke, Acute","enrollment":516},{"nctId":"NCT05601999","phase":"PHASE3","title":"Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction","status":"RECRUITING","sponsor":"AO GENERIUM","startDate":"2021-09-03","conditions":"ST Elevation Myocardial Infarction","enrollment":244},{"nctId":"NCT05105633","phase":"PHASE2, PHASE3","title":"Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2021-11-29","conditions":"Basilar Artery Occlusion","enrollment":688},{"nctId":"NCT04516993","phase":"PHASE2","title":"CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II","status":"COMPLETED","sponsor":"Huashan Hospital","startDate":"2021-09-28","conditions":"Stroke","enrollment":224},{"nctId":"NCT05809921","phase":"","title":"Dual IntraVenous Thrombolysis Approach (DIVA) in Patients With Medium-vessel-occlusion Strokes: a Retrospective Study","status":"COMPLETED","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2023-05-17","conditions":"Acute Ischemic Stroke Due to Medium-vessel-occlusion","enrollment":294},{"nctId":"NCT05733507","phase":"","title":"Tirofiban Plus Intravenous Thrombolysis in Acute Anterior Choroidal Infarction or Paramedian Pontine Infarction","status":"COMPLETED","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2023-04-03","conditions":"Acute Anterior Choroidal Infarction (ACI), Paramedian Pontine Infarction (IPP)","enrollment":48},{"nctId":"NCT06078995","phase":"","title":"Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China","status":"UNKNOWN","sponsor":"Huashan Hospital","startDate":"2023-04-02","conditions":"Ischemic Stroke","enrollment":1200},{"nctId":"NCT03889249","phase":"PHASE3","title":"Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2019-12-10","conditions":"Stroke, Acute, Thromboses, Intracranial","enrollment":1600},{"nctId":"NCT05745259","phase":"PHASE3","title":"Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2022-10-26","conditions":"Acute Ischemic Stroke","enrollment":1630},{"nctId":"NCT05634382","phase":"PHASE3","title":"Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-12-03","conditions":"Stroke, Acute Ischemic","enrollment":222},{"nctId":"NCT04797013","phase":"PHASE3","title":"Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅱ","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2021-06-12","conditions":"Acute Ischemic Stroke","enrollment":1430},{"nctId":"NCT05626972","phase":"PHASE3","title":"Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy","status":"UNKNOWN","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2022-05-27","conditions":"Acute Ischemic Stroke","enrollment":500},{"nctId":"NCT05534360","phase":"","title":"Tenecteplase Treatment in Ischemic Stroke Registry","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-09","conditions":"Stroke, Acute","enrollment":5000},{"nctId":"NCT05281549","phase":"PHASE2","title":"Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2021-05-02","conditions":"Acute Ischemic Stroke","enrollment":225},{"nctId":"NCT04086147","phase":"PHASE2","title":"CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase","status":"COMPLETED","sponsor":"Huashan Hospital","startDate":"2019-12-09","conditions":"Stroke","enrollment":86},{"nctId":"NCT04071613","phase":"PHASE2","title":"Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance","status":"COMPLETED","sponsor":"Melbourne Health","startDate":"2019-06-20","conditions":"Stroke, Acute, Stroke Ischemic","enrollment":104},{"nctId":"NCT04558125","phase":"PHASE4","title":"Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism","status":"TERMINATED","sponsor":"Cedars-Sinai Medical Center","startDate":"2020-09-08","conditions":"Pulmonary Embolism, COVID","enrollment":2},{"nctId":"NCT03181360","phase":"PHASE3","title":"Tenecteplase in Wake-up Ischaemic Stroke Trial","status":"UNKNOWN","sponsor":"University Hospital of North Norway","startDate":"2017-06-12","conditions":"Ischemic Stroke, Stroke, Acute","enrollment":600},{"nctId":"NCT01654445","phase":"PHASE2","title":"TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2012-07","conditions":"Ischemic Stroke","enrollment":50},{"nctId":"NCT03340493","phase":"PHASE2","title":"Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)","status":"COMPLETED","sponsor":"Neuroscience Trials Australia","startDate":"2017-12-06","conditions":"Ischemic Stroke","enrollment":300},{"nctId":"NCT01472926","phase":"PHASE2","title":"Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)","status":"COMPLETED","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2011-12","conditions":"Stroke","enrollment":104},{"nctId":"NCT02338466","phase":"PHASE2","title":"Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion","status":"WITHDRAWN","sponsor":"University Hospital Center of Martinique","startDate":"2016-07","conditions":"Nervous System Disorders, Cerebral Artery","enrollment":""},{"nctId":"NCT02388061","phase":"PHASE2","title":"Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke","status":"COMPLETED","sponsor":"Neuroscience Trials Australia","startDate":"2015-03-23","conditions":"Ischemic Stroke","enrollment":202}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":102,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Metalyse","TNK"],"phase":"phase_3","status":"active","brandName":"Intravenous Tenecteplase","genericName":"Intravenous Tenecteplase","companyName":"NHS Greater Glasgow and Clyde","companyId":"nhs-greater-glasgow-and-clyde","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tenecteplase is a tissue plasminogen activator (tPA) that converts plasminogen to plasmin, which breaks down fibrin clots to restore blood flow. Used for Acute myocardial infarction (ST-elevation MI), Acute ischemic stroke.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}